Ticker > Company >

Bayer CropScience share price

Bayer CropScience Ltd.

  1.76 L   432   30 NSE: BAYERCROP BSE: 506285 SECTOR: Pesticides & Agrochemicals

3492.00
+110.40 (3.26%)
NSE: 09 Oct 4:00 PM

Price Summary

Today's High

₹ 3529

Today's Low

₹ 3370.8

52 Week High

₹ 5149.9

52 Week Low

₹ 3366.3

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 15693.78 Cr.

Enterprise Value

₹ 14271.98 Cr.

No. of Shares

4.49 Cr.

P/E

21.44

P/B

4.77

Face Value

₹ 10

Div. Yield

4.29 %

Book Value (TTM)

₹  731.46

CASH

₹ 1421.8 Cr.

DEBT

₹ 0 Cr.

Promoter Holding

71.43 %

EPS (TTM)

₹  162.9

Sales Growth

3.68%

ROE

23.7 %

ROCE

30.08%

Profit Growth

21.34 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year3.68%
3 Year3.36%
5 Year5.9%

Profit Growth

1 Year21.34%
3 Year-3.13%
5 Year6.93%

ROE%

1 Year23.7%
3 Year23.42%
5 Year24.93%

ROCE %

1 Year30.08%
3 Year30.02%
5 Year32.52%

Debt/Equity

0

Price to Cash Flow

14.55

Interest Cover Ratio

44.1768

CFO/PAT (5 Yr. Avg.)

0.916411854639539

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2026 71.43 0.00
Mar 2026 71.43 0.00
Dec 2025 71.43 0.00
Sep 2025 71.43 0.00
Jun 2025 71.43 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company has been maintaining healthy ROE of 23.4199% over the past 3 years.
  • Company has been maintaining healthy ROCE of 30.0186666666667% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 44.1768.
  • The company has an efficient Cash Conversion Cycle of 47.2979 days.
  • The company has a high promoter holding of 71.43%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 3.33287883685069.

 Limitations

  • The company has shown a poor profit growth of -3.13047662438349% for the Past 3 years.
  • The company has shown a poor revenue growth of 3.35763303022973% for the Past 3 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Net Sales 1914.6 1553.4 1106.2 1100.8 1835
Total Expenditure 1566.2 1348.1 989.1 897.9 1467.4
Operating Profit 348.4 205.3 117.1 202.9 367.6
Other Income 18.7 13.8 15.9 46.6 88.9
Interest 4.7 4.4 5.2 5.5 4.3
Depreciation 27.2 14.4 14.8 37.6 50.1
Exceptional Items 0 0 0 0 0
Profit Before Tax 335.2 200.3 113 206.4 402.1
Tax 56.5 47.6 17.3 44.3 80.5
Profit After Tax 278.7 152.7 95.7 162.1 321.6
Adjusted EPS (Rs) 62.07 34.01 21.31 36.1 71.63

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales 4734.4 5139.7 5106.2 5473.4 5675
Total Expenditure 3928.6 4224.5 4152.4 4785.4 4804.9
Operating Profit 805.8 915.2 953.8 688 870.1
Other Income 59.9 72.9 81.2 121.3 98.6
Interest 12.9 22.3 19.6 17 19.8
Depreciation 64.5 79.5 74 84.9 94
Exceptional Items 58.5 103.8 0 0 0
Profit Before Tax 846.8 990.1 941.4 707.4 854.9
Tax 201.5 231.9 200.9 139.4 165.7
Net Profit 645.3 758.2 740.5 568 689.2
Adjusted EPS (Rs.) 143.72 168.86 164.92 126.5 153.5

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity and Liabilities
Share Capital 44.9 44.9 44.9 44.9 44.9
Total Reserves 2479.4 2667.2 2804.5 2805.5 2920.8
Borrowings 0 0 0 0 0
Other N/C liabilities 2364.5 2792.4 2951.9 3116.6 3107.8
Current liabilities 2072.9 1995.1 1815 2441.3 2947.1
Total Liabilities 6961.7 7499.6 7616.3 8408.3 9020.6
Assets
Net Block 441.4 436.8 389.4 445.1 434.3
Capital WIP 13.3 2.9 6.4 0.5 4.9
Intangible WIP 85 106.3 112.2 118.2 122.5
Investments 0 0 0 0 0
Loans & Advances 2406.3 2813.6 2959.7 3130.4 3136.6
Other N/C Assets 26.6 26 25.5 24.9 24.4
Current Assets 3989.1 4114 4123.1 4689.2 5297.9
Total Assets 6961.7 7499.6 7616.3 8408.3 9020.6
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Profit from operations 846.8 990.1 941.4 707.4 854.9
Adjustment 39.1 -0.4 108.4 81.5 86.5
Changes in Assets & Liabilities -406.2 -140.9 33.9 -365.1 300.6
Tax Paid -264.2 -239.5 -132.1 -161.8 -163.5
Operating Cash Flow 215.5 609.3 951.6 262 1078.5
Investing Cash Flow 64.2 83.3 0.4 85.6 72.5
Financing Cash Flow -703.3 -613.2 -656.3 -619.4 -623.8
Net Cash Flow -423.6 79.4 295.7 -271.8 527.2

Corporate Actions

Investors Details

Annual Reports

Title Link
Title Link
Annual Report 2026
Annual Report 2024
Annual Report 2023
Annual Report 2022
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit CRISIL
Credit CRISIL
Credit CRISIL
TYPE AGENCY Link
TYPE AGENCY Link
Research HDFC Securities
Research Prabhudas Lilladhar

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q1FY25
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY23
Presentation Q4FY22
Presentation Q4FY22
Presentation Q4FY21
Presentation Q3FY21
Presentation Q2FY26
Presentation Q2FY22
Presentation Q2FY21
Presentation Q3FY20

Company News

Bayer CropScience Stock Price Analysis and Quick Research Report. Is Bayer CropScience an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Bayer CropScience. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Bayer CropScience has a PE ratio of 21.4366614793875 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Bayer CropScience has ROA of 7.9087% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Bayer CropScience has a Current ratio of 1.7977.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Bayer CropScience has a ROE of 23.6997%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Bayer CropScience has a Debt to Equity ratio of 0 which means that the company has low proportion of debt in its capital.

  • Sales growth: Bayer CropScience has reported revenue growth of 3.6833% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Bayer CropScience for the current financial year is 15.3321585903084%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Bayer CropScience is Rs 150 and the yield is 4.2913%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Bayer CropScience is Rs 162.8985. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Bayer CropScience in Ticker for free. Also, one can get the intrinsic value of Bayer CropScience by using Valuation Calculators, which are available with a Finology ONE subscription. 

Bayer CropScience FAQs

Q1. What is Bayer CropScience share price today?
Ans: The current share price of Bayer CropScience is Rs 3492.

Q2. What is the market capitalisation of Bayer CropScience?
Ans: Bayer CropScience has a market capitalisation of Rs 15693.7785264 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Bayer CropScience?
Ans: The PE ratio of Bayer CropScience is 21.4366614793875 and the P/B ratio of Bayer CropScience is 4.77400252125299, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Bayer CropScience share?
Ans: The 52-week high share price of Bayer CropScience is Rs 5149.9, and the 52-week low share price of Bayer CropScience is Rs 3366.3.

Q5. Does Bayer CropScience pay dividends?
Ans: Currently, Bayer CropScience pays dividends. Dividend yield of Bayer CropScience is around 4.2913%.

Q6. What are the face value and book value of Bayer CropScience shares?
Ans: The face value of Bayer CropScience shares is Rs 10, while the book value per share of Bayer CropScience is around Rs 731.4617. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Bayer CropScience?
Ans: Bayer CropScience has a total debt of Rs 0 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Bayer CropScience?
Ans: The ROE of Bayer CropScience is 23.6997% and ROCE of Bayer CropScience is 30.0786%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Bayer CropScience a good buy for the long term?
Ans: The Bayer CropScience long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Bayer CropScience undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Bayer CropScience appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Bayer CropScience’s financials?
Ans: You can review Bayer CropScience’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Bayer CropScience
X